Goodwill and Other Intangible Assets

12 Months Ended

Apr. 02, 2011

Goodwill and Other Intangible Assets [Abstract]

GOODWILL AND OTHER INTANGIBLE ASSETS

6.   GOODWILL AND OTHER INTANGIBLE ASSETS

The changes in the carrying amount of goodwill for fiscal year 2011, 2010, and 2009 are as follows:

	(In thousands)
Carrying amount as of March 28, 2009	$	56,426
Global Med(c)		39,554
SEBRA(d)		3,521
L’Attitude Medical Systems Inc. (Neoteric)(e)		8,186
Altivation Software Inc.(b)		2,110
Medicell Ltd.(a)		583
Effect of change in foreign currency exchange rates		(392	)
Carrying amount as of April 3, 2010	$	109,988
SEBRA		163
Altivation Software Inc.		228
ACCS(f)		2,662
Effect of change in foreign currency exchange rates		2,326
Carrying amount as of April 2, 2011	$	115,367

(a)	See Note 3, Acquisitions, for a full description of the acquisition of Medicell Limited (“Medicell”), which occurred on April 4, 2008.
(b)	See Note 3, Acquisitions, for a full description of the acquisition of Altivation Software (“Altivation”), which occurred on March 27, 2009.

(c)	See Note 3, Acquisitions, for a full description of the acquisition of Global Med Technologies, Inc.(“Global Med”), which occurred on March 31, 2010.
(d)	See Note 3, Acquisitions, for a full description of the acquisition of the SEBRA® assets, which occurred on September 4, 2009.
(e)	See Note 3, Acquisitions, for a full description of the acquisition of L’Attitude Medical Systems, Inc. (“Neoteric”), which occurred on April 16, 2009.
(f)	See Note 3, Acquisitions, for a full description of the acquisition of Applied Critical Care Services, Inc. (“ACCS”), which occurred on December 28, 2010.

Other Intangible Assets

Other intangible assets include the value assigned to license rights and other technology, patents, customer contracts and relationships, software technology, and a trade name. The estimated useful lives for all of these intangible assets are 5 to 20 years.

Aggregate amortization expense for amortized other intangible assets for fiscal year 2011, 2010, and 2009 was $11.1 million, $7.7 million, and $6.0 million, respectively. Future annual amortization expense on other intangible assets is expected to approximate $11.9 million for fiscal year 2012, $12.8 million for fiscal year 2013, $12.6 million for fiscal year 2014, $11.1 million for fiscal year 2015 and $10.7 million for fiscal year 2016.

Amortized Intangibles

	Gross Carrying		Accumulated		Weighted Average
	Amount		Amortization		Useful Life
	(In thousands)		(In thousands)		(In years)
As of April 2, 2011
Patents	$	12,704	$	6,827		11
Capitalized software		14,506		656		6
Other technology		43,244		17,391		11
Customer contracts and related relationships		69,908		17,740		12
Trade names		5,254		1,213		10
Total intangibles	$	145,616	$	43,827		11

	Gross Carrying		Accumulated		Weighted Average
	Amount		Amortization		Useful Life
	(In thousands)		(In thousands)		(In years)
As of April 3, 2010
Patents	$	11,928	$	5,801		11
Capitalized software		7,642		498		6
Other technology		43,240		14,187		10
Customer contracts and related relationships		65,011		11,549		11
Trade names		4,932		658		7
Total intangibles	$	132,753	$	32,693		10

In addition to the acquisitions of SEBRA, Neoteric, Global Med, and ACCS discussed in Note 3, changes to the net carrying value of our intangible assets from April 3, 2010 to April 2, 2011 reflect the capitalization of software costs associated with our devices and software products (see Note 17), amortization expense and the effect of exchange rate changes in the translation of our intangible assets held by our international subsidiaries.